Evaluation of Recombinant Attenuated Salmonella Vaccine Strains for Broad Protection against Extraintestinal Pathogenic Escherichia coli.
Evaluation of Recombinant Attenuated Salmonella Vaccine Strains for Broad Protection against Extraintestinal Pathogenic Escherichia coli.
复制标题
DOI:
10.3389/fimmu.2017.01280
复制
发表时间:
2017
影响因子:
7.3
通讯作者:
Mellata M
中科院分区:
文献类型:
--
作者:
Maddux JT;Stromberg ZR;Curtiss Iii R;Mellata M
Antibiotic-resistant bacterial infections are difficult to treat, producing a burden on healthcare and the economy. Extraintestinal pathogenic Escherichia coli (ExPEC) strains frequently carry antibiotic resistance genes, cause infections outside of the intestine, and are causative agents of hospital-acquired infections. Developing a prevention strategy against this pathogen is challenging due to its antibiotic resistance and antigenic diversity. E. coli common pilus (ECP) is frequently found in ExPEC strains and may serve as a common antigen to induce protection against several ExPEC serotypes. In addition, live recombinant attenuated Salmonella vaccine (RASV) strains have been used to prevent Salmonella infection and can also be modified to deliver foreign antigens. Thus, the objective of this study was to design a RASV to produce ECP on its surface and assess its ability to provide protection against ExPEC infections. To constitutively display ECP in a RASV strain, we genetically engineered a vector (pYA4428) containing aspartate-β-semialdehyde dehydrogenase and E. coli ecp genes and introduced it into RASV χ9558. RASV χ9558 containing an empty vector (pYA3337) was used as a control to assess protection conferred by the RASV strain without ECP. We assessed vaccine efficacy in in vitro bacterial inhibition assays and mouse models of ExPEC-associated human infections. We found that RASV χ9558(pYA4428) synthesized the major pilin (EcpA) and tip pilus adhesin (EcpD) on the bacterial surface. Mice orally vaccinated with RASV χ9558(pYA3337) without ECP or χ9558(pYA4428) with ECP, produced anti-Salmonella LPS and anti-E. coli EcpA and EcpD IgG and IgA antibodies. RASV strains showed protective potential against some E. coli and Salmonella strains as assessed using in vitro assays. In mouse sepsis and urinary tract infection challenge models, both vaccines had significant protection in some internal organs. Overall, this work showed that RASVs can elicit an immune response to E. coli and Salmonella antigens in some mice, provide significant protection in some internal organs during ExPEC challenge, and thus this study is a promising initial step toward developing a vaccine for prevention of ExPEC infections. Future studies should optimize the ExPEC antigens displayed by the RASV strain for a more robust immune response and enhanced protection against ExPEC infection.
登录
查看更多内容
影响因子:
3.7
作者:
Kalyoussef S;Nieves E;Dinerman E;Carpenter C;Shankar V;Oh J;Burd B;Angeletti RH;Buckheit KW;Fredricks DN;Madan RP;Keller MJ;Herold BC
通讯作者:
Herold BC
影响因子:
1.8
作者:
Hays MP;Ericsson AC;Yang Y;Hardwidge PR
通讯作者:
Hardwidge PR
影响因子:
--
作者:
Gunn, Bronwyn M.;Wanda, Soo-Young;Curtiss, Roy, III
通讯作者:
Curtiss, Roy, III
影响因子:
3.1
作者:
Dolores Juarez-Rodriguez, Maria;Arteaga-Cortes, Lourdes T.;Clark-Curtiss, Josephine E.
通讯作者:
Clark-Curtiss, Josephine E.
影响因子:
5.5
作者:
Galen, James E.;Curtiss, Roy, III
通讯作者:
Curtiss, Roy, III